Kyle Salsbery Genetic Counselor

Slides:



Advertisements
Similar presentations
Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
Advertisements

Medical Genomics Promise, Peril and Price. Alison J Whelan M.D., FACP Professor of Medicine and Pediatrics Director of the Hereditary Cancer Clinic Washington.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
10 November 2011 Genetic counseling for breast cancer risk Aichu Huang, MS. CGC. Department of Medical Genetics National Taiwan University Hospital.
Hereditary Factors in Breast Cancer
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
GenetiKit Workshop Given by: Dr. Sean Blaine, Family Physician Dr. June Carroll, Family Physician Clare Gibbons, Genetic Counsellor Cathy Gilpin, Genetic.
Hereditary Breast & Ovarian Cancer Syndrome HBOC Tammy McKamie RN MSN OCN Cancer Genetics Educator Clinical Oncology Patient Navigator.
Breast Cancer Risk and Risk Assessment Models
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Breast Cancer By Kajal Haghmoradi.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
The genetic epidemiology of common hormonal cancers Deborah Thompson Centre for Cancer Genetic Epidemiology.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Genetics and Ovarian Cancer June 16, 2015 Ovarian Cancer Alliance of Oregon and SW Washington Becky Clark, MS, CGC Genetic Counselor.
Breast cancer screening Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years Clinical breast.
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center.
Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Genetics: For this Generation and the Next
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
Uterine Cancer Endometrial (or uterine) cancer will account for 50,000 new cases and 8200 deaths in the United States in Two genetic disorders are.
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment Volume 32, Number 19, July. 1, 2014, from J Clin Oncol Chen.
Prostate Cancer There are roughly 240,000 cases of prostate cancer diagnosed in the United States each year, making it the most common cancer in males.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
Breast Cancer Ten percent of breast cancer is hereditary. Or 23,000 women a year with a genetic basis for their cancer. The most common mutations in this.
What Percentage of Cancer is Considered to be Hereditary?
Genetic Counseling Yahwardiah Siregar Sry Suryani W Mutiara Indah Sari.
The Elliott Breast Center * Baton Rouge, LA *
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
Update on genetic testing for hereditary breast cancer syndromes Kristin DePrince Mattie, M.S. Licensed / Certified Genetic Counselor William G. Rohrer.
An Introduction to Cancer Genetics for Healthcare Interpreters Cynthia Roat, MPH; Galen Joseph, PhD Claudia Guerra MSW; Janice Cheng, PhD Robin Lee, LCGC;
Refer to Beds & Herts Breast Cancer Family History Screening service
Hereditary Cancer Predisposition: Updates in Genetic Testing
Pathways involved in hereditary breast cancer
Kristen Zarfos, MD Linda Steinmark, MS, LCGC
Beaumont Hospital Breast Service
Karyotyping Cancer.
A consultand is an individual under evaluation for predicting his or her own future risk or the risk of his or her offspring. The arrow identifies the.
Breast Cancer Screening/Imaging
Susan Domchek, MD University of Pennsylvania
Demystifying Cancer Genetics
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.

Brady A. F. 1, Taylor A2, Lachlan K. L. 3 1
Cancer screening PROF .MAZIN AL-HAWAZ.
Family Tree Presentation
GYN CANCER RISK AND GENETICS
Breast Screening and Risk Assessment
Genetic Testing for Inherited Cancers
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Refer to Beds & Herts Breast Cancer Family History Screening service
Deborah O. Himes, PhD, ANP-BC, Aubri E
Genetics and Breast Cancer Adelphi 2018 Educational Forum Sharona Cohen, MS, CGC Certified Genetic Counselor Northwell Health.
Lorraine Hartles West Midlands Regional Genetics Laboratory
Counseling Patients About Germline BRCA Mutations
Genetic Counseling & Testing for Cancer Risk
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer 
Genetic Cancer Screening
Genetic Cancer Screening Medicare Insurance Clients
Biology of hereditary breast and ovarian cancer (HBOC)
HBOC Genetic counseling: major concerns and communication skills
by Jennifer Couzin-Frankel
INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT
INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT
Breast Cancer BRCA testing protocol
Breast cancer BRCA testing protocol
Presentation transcript:

Kyle Salsbery Genetic Counselor salsbery.kyle@marshfieldclinic.org Beyond BRCA1/2 Kyle Salsbery Genetic Counselor salsbery.kyle@marshfieldclinic.org

Outline Who we see in genetics and how to refer Testing options Cancer risk genes: CHEK2, PALB2, TP53 Test results and recommendations Family history examples

Who we see in genetics General genetics clinic Cancer Multiple generations affected Early onset Rare cancers Old age does not disqualify Indication of family history alone

NCCN guidelines for further genetic risk evaluation Ovarian cancer Breast cancer and Known familial mutation Diagnosed ≤ 50 TNBC ≤ 60 Significant family history Male breast cancer Family history alone

Referral process Referral manager Outside referral Family history questionnaire Telehealth Genetics will check with insurance coverage for appointment

Genetic Screening Form

Krames tool and also have specific ones for ovarian, colon, and endometrial

T/F questions of referral to genetics

Cancer Genetic Testing Options Next-generation sequencing technology Panel testing More personalized Wordle image

Cancer Risk Genes BRCA1/2 CHEK2 PALB2 TP53

BRCA1/2 Breast, Ovarian, but more…MBC, melanoma, pancreatic State recommendations

Evidence for Panel testing

Beyond BRCA1/2

Beyond BRCA1/2

Family History Example

CHEK2 Cancer Risks Breast Prostate Colon Screening Family testing

Family History Example

PALB2 Cancer Risks Breast Pancreatic Screening

Family History Example

TP53 Cancer Risks Lifetime risk up to 90% Screening

Multiple Testing Indications

Test Results Positive Negative Variant of uncertain significance Screening recommendations Referrals Negative Cancer risk models Variant of uncertain significance Family studies

Insurance

Always a Surprise

Challenges Context, context, context Newer/moderate risk genes Discrepancies between interpretations

Questions